Join us for an EBAC-accredited satellite symposium focusing on the use and interpretation of multimodality imaging in the care of obstructive hypertrophic cardiomyopathy.
For more information, please visit the EACVI website.
advertisement
From Pixels to Practice: Advancing HCM Care With Multimodality Imaging
Stay up to date on oHCM care! We welcome you to attend our EBAC-accredited satellite symposium during the EACVI Congress 2025 in Vienna, Austria.
Live
Meeting
1.00 available credits
Information
12 december, 2025
12:30 - 13:30 CET
VIECON – Vienna Congress & Convention Center
Room: EuroEcho2, Messeplatz 1, 1020, Vienna, Austria
Share
Share
Share
Share this program on:
Details
Presenters
Agenda
12:30 – 12:35 Welcome & Introduction
12:35 – 12:45 Inside the Hypertrophic Heart: Contemporary Insights Into HCM Pathophysiology
12:45 – 13:00 Echocardiography and Beyond: Comprehensive Imaging Strategies for HCM Evaluation
13:00 – 13:15 From Therapy to Outcomes: Imaging-Guided Assessment in oHCM
13:15 – 13:30 Panel Discussion and Audience Q&ADisclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, it is the policy of MEDCON International that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. MEDCON International has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.Chair:
Marc Dweck, BSc, MBChB, PhD, FRCP, FRSE
Professor of Clinical Cardiology
Vice-President European Association of Cardiovascular Imaging
University of Edinburgh
Edinburgh, United Kingdom
Dr. Dweck has no relevant relationships to disclose.
Faculty:
Jeanette Schulz-Menger, MD
Charité Campus Buch
University Medicine Berlin
Berlin, Germany
Dr. Schulz-Menger has no relevant relationships to disclose.
Tomaž Podlesnikar, MD, PhD
Department of Cardiac Surgery, University Medical Centre Maribor
Department of Cardiology, University Medical Centre Ljubljana
Assistant Professor, Faculty of Medicine, University of Maribor
Chair of the Working Group for Cardiovascular Imaging, Slovenian Society of Cardiology
Maribor, Slovenia
Dr. Podlesnikar has no relevant relationships to disclose.Reviewers/Content Planners/Authors:
- Cindy Davidson has no relevant relationships to disclose.
- Anja Gerrits, PhD, has no relevant relationships to disclose.
- Brian P. McDonough, MD, FAAFP, has no relevant relationships to disclose.
Learning Objectives
Upon completion of this activity, learners should be better able to:
- Describe the role of various imaging modalities important in the diagnosis and prognosis of hypertrophic cardiomyopathy (HCM)
- Recognize imaging patterns indicative of HCM that warrant the application of an HCM-specific treatment approach
- Interpret imaging findings of patients with HCM to correctly monitor treatment
Target Audience
This activity has been designed to meet the educational needs of cardiologists and sonographers as well as all other healthcare providers involved in managing patients with hypertrophic cardiomyopathy.
Accreditation and Credit Designation Statements
This activity has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®). Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association physicians may convert EBAC® CE credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.
This live activity is accredited by the European Board for Accreditation of Continuing Education for Health Professional (EBAC®) for 60 minutes of effective education time.
Provider(s)/Educational Partner(s)
Today’s healthcare environment is constantly evolving and advances of medical science occur at an accelerating pace. CME/CE plays an important role in the clinical environment and is an essential element of physician training, learning, and improvement, thereby importantly contributing to optimal patient care. Since 2000, MEDCON’s mission is to deliver high quality within the world of medical education by creating forums like PACE-CME, organizing live meetings, and providing online education. We aim to stimulate the review, exchange, and assimilation of key scientific findings to improve patients’ health, to raise awareness of new science underlying various disease states, and to accelerate the translation of this information into clinical practice.Commercial Support
This activity is supported by an independent educational grant from Bristol Myers Squibb.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MEDCON. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information.
Reproduction Prohibited Reproduction of this material is not permitted without written permission from the copyright owner.
Details
Presenters
Overview
Join us for an EBAC-accredited satellite symposium focusing on the use and interpretation of multimodality imaging in the care of obstructive hypertrophic cardiomyopathy.
For more information, please visit the EACVI website.
Agenda
12:30 – 12:35 Welcome & Introduction
12:35 – 12:45 Inside the Hypertrophic Heart: Contemporary Insights Into HCM Pathophysiology
12:45 – 13:00 Echocardiography and Beyond: Comprehensive Imaging Strategies for HCM Evaluation
13:00 – 13:15 From Therapy to Outcomes: Imaging-Guided Assessment in oHCM
13:15 – 13:30 Panel Discussion and Audience Q&ADisclosure of Relevant Financial Relationships
In accordance with the ACCME Standards for Integrity and Independence, it is the policy of MEDCON International that faculty and other individuals who are in the position to control the content of this activity disclose any real or apparent financial relationships relating to the topics of this educational activity. MEDCON International has full policies in place that have identified and mitigated financial relationships and conflicts of interest to ensure independence, objectivity, balance, and scientific accuracy prior to this educational activity.
The following faculty/staff members have reported financial relationships with ineligible companies within the last 24 months.Chair:
Marc Dweck, BSc, MBChB, PhD, FRCP, FRSE
Professor of Clinical Cardiology
Vice-President European Association of Cardiovascular Imaging
University of Edinburgh
Edinburgh, United Kingdom
Dr. Dweck has no relevant relationships to disclose.
Faculty:
Jeanette Schulz-Menger, MD
Charité Campus Buch
University Medicine Berlin
Berlin, Germany
Dr. Schulz-Menger has no relevant relationships to disclose.
Tomaž Podlesnikar, MD, PhD
Department of Cardiac Surgery, University Medical Centre Maribor
Department of Cardiology, University Medical Centre Ljubljana
Assistant Professor, Faculty of Medicine, University of Maribor
Chair of the Working Group for Cardiovascular Imaging, Slovenian Society of Cardiology
Maribor, Slovenia
Dr. Podlesnikar has no relevant relationships to disclose.Reviewers/Content Planners/Authors:
- Cindy Davidson has no relevant relationships to disclose.
- Anja Gerrits, PhD, has no relevant relationships to disclose.
- Brian P. McDonough, MD, FAAFP, has no relevant relationships to disclose.
Learning Objectives
Upon completion of this activity, learners should be better able to:
- Describe the role of various imaging modalities important in the diagnosis and prognosis of hypertrophic cardiomyopathy (HCM)
- Recognize imaging patterns indicative of HCM that warrant the application of an HCM-specific treatment approach
- Interpret imaging findings of patients with HCM to correctly monitor treatment
Target Audience
This activity has been designed to meet the educational needs of cardiologists and sonographers as well as all other healthcare providers involved in managing patients with hypertrophic cardiomyopathy.
Accreditation and Credit Designation Statements
This activity has been accredited by the European Board for Accreditation of Continuing Education for Health Professionals (EBAC®). Through an agreement between the European Board for Accreditation of Continuing Education for Health Professionals and the American Medical Association physicians may convert EBAC® CE credits to AMA PRA Category 1 Credits™. Information on the process to convert EBAC credit to AMA credit can be found on the AMA website. Other health care professionals may obtain from the AMA a certificate of having participated in an activity eligible for conversion of credit to AMA PRA Category 1 Credit™.
This live activity is accredited by the European Board for Accreditation of Continuing Education for Health Professional (EBAC®) for 60 minutes of effective education time.
Provider(s)/Educational Partner(s)
Today’s healthcare environment is constantly evolving and advances of medical science occur at an accelerating pace. CME/CE plays an important role in the clinical environment and is an essential element of physician training, learning, and improvement, thereby importantly contributing to optimal patient care. Since 2000, MEDCON’s mission is to deliver high quality within the world of medical education by creating forums like PACE-CME, organizing live meetings, and providing online education. We aim to stimulate the review, exchange, and assimilation of key scientific findings to improve patients’ health, to raise awareness of new science underlying various disease states, and to accelerate the translation of this information into clinical practice.Commercial Support
This activity is supported by an independent educational grant from Bristol Myers Squibb.
Disclaimer
The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MEDCON. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information.
Reproduction Prohibited Reproduction of this material is not permitted without written permission from the copyright owner.
Recommended
New Insights in the Management of HCM: Exploring the Clinical Spectrum
New Insights in the Management of HCM: Exploring the Clinical Spectrum
CME/CE Broadcast ReplayNew Insights in the Management of HCM: Exploring the Clinical Spectrum
0.50 credits
Milind Y. Desai, MD, MBA
Iacopo Olivotto, MD
Elena Arbelo, MD, PhD
0.50 creditsUnderstanding hypertrophic cardiomyopathy and recent guidelines
Understanding hypertrophic cardiomyopathy and recent guidelines
MinuteCE®Understanding hypertrophic cardiomyopathy and recent guidelines
0.52 program creditsElena Arbelo, MD, PhD
0.52 program creditsRole of echocardiography in risk stratification and treatment decision-making
Role of echocardiography in risk stratification and treatment decision-making
MinuteCE®Role of echocardiography in risk stratification and treatment decision-making
0.52 program creditsMaurizio Pieroni, MD, PhD
0.52 program creditsHCM: Understanding the condition
HCM: Understanding the condition
MinuteCE®HCM: Understanding the condition
1.00 program creditPerry Elliott, MD
1.00 program credit